SLC35C1 and malignant colon neoplasm: For example, Villar‐Portela et al documented an increase in the level of FX enzyme and GDP‐L‐Fuc transporter in colon cancer.40 On the contrary, our study discovered that SLC35C1 was decreased in colon cancer.